Effect of complete fasting and two hours after meal on the pharmacokinetics of Erlotinib in NSCLC patients
Latest Information Update: 06 Jan 2020
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- 07 Jan 2013 New trial record